Results 111 to 120 of about 6,898 (170)

Management of malaria in newborns: a systematic review. [PDF]

BMC Infect Dis
Sultanli A, Beck JS, Kremp M, Sondermann H, Bonitz M, Honkpehedji YJ, Remppis J, Adegnika AA, Esen M, Bélard S.   +9 more
europepmc   +1 more source

Dose-Optimization of a Novel Co-Formulated Triple Combination Antimalarial Therapy: Artemether-Lumefantrine-Amodiaquine. [PDF]

Clin Pharmacol Ther
Tarning J, White NJ, Dondorp AM.
europepmc   +1 more source

Indirect benefits of seasonal malaria chemoprevention for non-malarial pediatric infections and routine antibiotic use in real-world programmatic settings: a pre-post study using positive and negative controls. [PDF]

BMC Infect Dis
Gebreegziabher EA, Ouattara M, Bountogo M, Coulibaly B, Boudo V, Ouedraogo T, Lebas E, Hu H, O'Brien KS, Hsiang MS, Glidden DV, Arnold BF, Lietman TM, Sié A, Oldenburg CE.   +14 more
europepmc   +1 more source

Associations between precipitation, temperature, and malaria prevalence in children under 5 in Mali. [PDF]

PLoS One
Hayden NJT, Syer J, Yanow SK, Yamamoto SS.   +3 more
europepmc   +1 more source

Natural Polymorphic Variants in the CYP450 Superfamily: A Review of Potential Structural Mechanisms and Functional Consequences. [PDF]

Int J Mol Sci
Prost R, Płaziński W.
europepmc   +1 more source

4-Aminoquinolines block heme iron reactivity and interfere with artemisinin action. [PDF]

Elife
Rosenthal M, Goldberg DE.
europepmc   +1 more source

Pharmacometric evaluation of amodiaquine-sulfadoxine-pyrimethamine and dihydroartemisinin-piperaquine seasonal malaria chemoprevention in northern Uganda

Bonnington C, Nuwa A, Theiss-Nyland K, Kajubi R, Kamya MR, Nankabirwa J, Ebong C, Rassi C, Nabakooza J, Opigo J, Salandindi D, Odongo M, Sararat C, Watson JA, Suwannasin K, Proux S, Koesukwiwat U, Tarning J, Imwong M, Tibenderana J, Nosten F, White N.   +21 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

AMODIAQUINE AGRANULOCYTOSIS

Medical Journal of Australia, 1977
A case of profound neutropenia and severe infection after the administration of amodiaquine is presented. The recommended dose for malaria prophylaxis was administered.
P, Gillespie, F, Wagner
openaire   +2 more sources

Amodiaquine Pharmacogenetics

Pharmacogenomics, 2008
Amodiaquine is a central drug in the new global strategy of combination therapies for the control of malaria. Amodiaquine is mainly metabolized hepatically towards its major active metabolite desethylamodiaquine, by the polymorphic P450 isoform CYP2C8.
openaire   +2 more sources

Amodiaquine and Hepatitis

Annals of Internal Medicine, 1986
Excerpt To the editor: Prophylaxis of malaria by amodiaquine is dangerous (1, 2). At least 20 cases of amodiaquine-associated agranulocytosis have been discovered so far in Switzerland, and 12 of t...
openaire   +1 more source